0001209191-19-024577.txt : 20190415 0001209191-19-024577.hdr.sgml : 20190415 20190415161219 ACCESSION NUMBER: 0001209191-19-024577 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190412 FILED AS OF DATE: 20190415 DATE AS OF CHANGE: 20190415 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RUBINO RICHARD J CENTRAL INDEX KEY: 0001252014 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36152 FILM NUMBER: 19748726 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001337553 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 203109565 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7020 KIT CREEK ROAD STREET 2: SUITE 270 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: 919-313-9650 MAIL ADDRESS: STREET 1: 7020 KIT CREEK ROAD STREET 2: SUITE 270 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-04-12 0 0001337553 AERIE PHARMACEUTICALS INC AERI 0001252014 RUBINO RICHARD J C/O AERIE PHARMACEUTICALS, INC. 4301 EMPEROR BLVD., SUITE 400 DURHAM NC 27703 0 1 0 0 Chief Financial Officer Common Stock 2019-04-12 4 F 0 1549 41.89 D 323169 D Reflects shares of Common Stock withheld to satisfy tax withholding obligations in connection with the vesting of performance-based restricted Common Stock. /s/ John LaRocca, Attorney-in-Fact for Richard J. Rubino 2019-04-15